EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis

Katya E Sosnovski, Tzipi Braun, Amnon Amir, Danielle Moshel, Marina BenShoshan, Kelli L VanDussen iD, Nina Levhar iD, Haya Abbas-Egbariya, Katia Beider, Rakefet Ben-Yishay, Syed Asad Ali, Sean R Moore und 12 weitere

Journal of Crohn's and Colitis · 16.06.2023 · 17 (6) · 960-971

DOI: 10.1093/ecco-jcc/jjad006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Crohn's and Colitis, online erschienen am 16.06.2023. Verfasst von Katya E Sosnovski und 23 weiteren Autor:innen. Beteiligte Einrichtung: Sheba Medical Center, Tel-Hashomer, affiliated with the Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Celiac Disease, Crohn Disease. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, ERC, Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Widespread dysregulation of long non-coding RNAs [lncRNAs] including a reduction in GATA6-AS1 was noted in inflammatory bowel disease [IBD]. We previously reported a prominent inhibition of epithelial mitochondrial functions in ulcerative colitis [UC]. However, the connection between reduction of GATA6-AS1 expression and attenuated epithelial mitochondrial functions was not defined.

Methods

Mucosal transcriptomics was used to conform GATA6-AS1 reduction in several treatment-naïve independent human cohorts [n=673]. RNA pull-down followed by mass spectrometry was used to determine the GATA6-AS1 interactome. Metabolomics and mitochondrial respiration following GATA6-AS1 silencing in Caco-2 cells were used to elaborate on GATA6-AS1 functions.

Results

GATA6-AS1 showed predominant expression in gut epithelia using single cell datasets. GATA6-AS1 levels were reduced in Crohn’s disease [CD] ileum and UC rectum in independent cohorts. Reduced GATA6-AS1 lncRNA was further linked to a more severe UC form, and to a less favourable UC course. The GATA6-AS1 interactome showed robust enrichment for mitochondrial proteins, and included TGM2, an autoantigen in coeliac disease that is induced in UC, CD and coeliac disease, in contrast to GATA6-AS1 reduction in these cohorts. GATA6-AS1 silencing resulted in induction of TGM2, and this was coupled with a reduction in mitochondrial membrane potential and mitochondrial respiration, as well as in a reduction of metabolites linked to aerobic respiration relevant to mucosal inflammation. TGM2 knockdown in GATA6-AS1-deficient cells rescued mitochondrial respiration.

Conclusions

GATA6-AS1 levels are reduced in UC, CD and coeliac disease, and in more severe UC forms. We highlight GATA6-AS1 as a target regulating epithelial mitochondrial functions, potentially through controlling TGM2 levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeCeliac DiseaseCrohn DiseaseHumansCaco-2 CellsIntestinal MucosaRectumInflammationMitochondriaGATA6 Transcription Factor

Stichwörter der Autor:innen

GATA6-AS1 long non-coding RNAinflammatory bowel diseasemitochondria

Substanzen

GATA6 protein, humanGATA6 Transcription Factor

Autor:innen und Institutionen

  • Sheba Medical Center, Tel-Hashomer, affiliated with the Tel Aviv University, Tel Aviv, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
  • Emory University, Atlanta, GA, USA.

ORCID-Profile: Kelli L VanDussen, Nina Levhar, Subra Kugathasan, Igor Ulitsky, Lee A Denson, Yael Haberman

Förderung

  • NIDDK NIH HHS
  • ERC
  • Israel Science Foundation
  • Helmsley Charitable Trust
  • NIDDK
  • Crohn's and Colitis Foundation
  • Bill and Melinda Gates Foundation

Zitieren

APA

Sosnovski, K. E., Braun, T., Amir, A., Moshel, D., BenShoshan, M., VanDussen, K. L., Levhar, N., Abbas-Egbariya, H., Beider, K., Ben-Yishay, R., Asad Ali, S., Moore, S. R., Kugathasan, S., Abramovich, I., Glick Saar, E., Weiss, B., Barshack, I., Gottlieb, E., Geiger, T., …, & Haberman, Y. (2023). GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis. Journal of Crohn's and Colitis, 17(6), 960-971. https://doi.org/10.1093/ecco-jcc/jjad006

Vancouver

Sosnovski KE, Braun T, Amir A, Moshel D, BenShoshan M, VanDussen KL, et al. GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis. Journal of Crohn's and Colitis. 2023;17(6):960-971. doi:10.1093/ecco-jcc/jjad006

BibTeX
@article{Sosnovski2023,
  author = {Sosnovski, Katya E and Braun, Tzipi and Amir, Amnon and Moshel, Danielle and BenShoshan, Marina and VanDussen, Kelli L and Levhar, Nina and Abbas-Egbariya, Haya and Beider, Katia and Ben-Yishay, Rakefet and Asad Ali, Syed and Moore, Sean R and Kugathasan, Subra and Abramovich, Ifat and Glick Saar, Efrat and Weiss, Batya and Barshack, Iris and Gottlieb, Eyal and Geiger, Tamar and Ben-Horin, Shomron and Ulitsky, Igor and Hyams, Jeffrey S and Denson, Lee A and Haberman, Yael},
  title = {GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis},
  journal = {Journal of Crohn's and Colitis},
  year = {2023},
  volume = {17},
  number = {6},
  pages = {960--971},
  doi = {10.1093/ecco-jcc/jjad006}
}
Kostenlos starten →